Literature DB >> 17420790

Modified inferior vena caval anastomosis to reduce tricuspid valve regurgitation after heart transplantation.

Daniel Marelli1, Scott C Silvestry, Donna Zwas, Paul Mather, Sharon Rubin, Anthony F Dempsey, Louis Stein, Evelio Rodriguez, James T Diehl, Arthur M Feldman.   

Abstract

Postoperative tricuspid valve regurgitation is moderate to severe in 15% to 20% of heart transplant recipients despite use of the bicaval surgical technique. We hypothesized that the regurgitation might be partly due to increased tension on the donor right atrium. To study the right atrial distortion, we modified the standard bicaval anastomosis. Our technique involves augmenting the donor right atrial anterior wall with a flap of the recipient's right atrium, which is left attached in continuity with the anterior aspect of the inferior vena cava along 65% of its circumference. We measured tricuspid regurgitation, right atrial area, and right atrioventricular diameter in 7 consecutive patients who underwent orthotopic heart transplantation with the modified anastomosis. Tricuspid regurgitation was graded as follows: 1 = trace, <10%; 2 = mild, 10%-24%; 3 = moderate, 25%-50%; and 4 = severe, >50%. All patients were weaned from inotropic support within 1 week after transplantation with excellent ventricular function, no heart block, and 100% survival at 30 days. The median follow-up time was 173 days (44-358 days). Other median measurements included tricuspid valve regurgitation jet area, 0.30 cm(2) (0-1.90 cm(2)); right atrial area, 15.90 cm(2) (14.47-18.00 cm(2)); atrioventricular diameter, 2.70 cm (2.63-3.09 cm); and tricuspid regurgitation, 1.67% (0-12.42%). Mild regurgitation occurred in 1 recipient; in all others, it was trace. The modified inferior vena caval anastomosis is simple and safe. It eliminates moderate and severe tricuspid valve regurgitation without routine annuloplasty after orthotopic heart transplantation via the bicaval technique.

Entities:  

Mesh:

Year:  2007        PMID: 17420790      PMCID: PMC1847922     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  17 in total

1.  Bicaval and standard techniques in orthotopic heart transplantation: medium-term experience in cardiac performance and survival.

Authors:  T Aziz; M Burgess; R Khafagy; A Wynn Hann; C Campbell; A Rahman; A Deiraniya; N Yonan
Journal:  J Thorac Cardiovasc Surg       Date:  1999-07       Impact factor: 5.209

2.  Quantification of tricuspid regurgitation by Doppler color flow mapping after cardiac transplantation.

Authors:  A Mügge; W G Daniel; G Herrmann; R Simon; P R Lichtlen
Journal:  Am J Cardiol       Date:  1990-10-01       Impact factor: 2.778

3.  Severe tricuspid regurgitation after heart transplantation.

Authors:  M C Chan; N Giannetti; T Kato; M Kornbluth; P Oyer; H A Valantine; R C Robbins; S A Hunt
Journal:  J Heart Lung Transplant       Date:  2001-07       Impact factor: 10.247

4.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

5.  Anatomic characteristics and valvular function of the transplanted heart: transthoracic versus transesophageal echocardiographic findings.

Authors:  C E Angermann; C H Spes; A Tammen; H U Stempfle; A Schütz; B M Kemkes; K Theisen
Journal:  J Heart Transplant       Date:  1990 Jul-Aug

6.  Optimal surgical management of severe tricuspid regurgitation in cardiac transplant patients.

Authors:  Farzan Filsoufi; Sacha P Salzberg; Curtis A Anderson; Gregory S Couper; Lawrence H Cohn; David H Adams
Journal:  J Heart Lung Transplant       Date:  2006-01-25       Impact factor: 10.247

7.  Avoidance of atrioventricular valve incompetence following orthotopic heart transplantation using direct bicaval anastomosis.

Authors:  A Forni; G Faggian; B Chiominto; G Perini; P Bertolini; M Zanini; A Mazzucco
Journal:  Transplant Proc       Date:  1995-12       Impact factor: 1.066

8.  Do donor characteristics really matter? Short- and long-term impact of donor characteristics on recipient survival, 1995-1999.

Authors:  Jonathan M Chen; Prashant Sinha; Hiranya A Rajasinghe; Sanjeev J Suratwala; Jonathan D McCue; Matthew J McCarty; Xzabia Caliste; Helen M Hauff; Ranjit John; Niloo M Edwards
Journal:  J Heart Lung Transplant       Date:  2002-05       Impact factor: 10.247

9.  Seventeen-year experience with 1,083 heart transplants at a single institution.

Authors:  Daniel Marelli; Hillel Laks; Jon A Kobashigawa; Jessica Bresson; Abbas Ardehali; Fardad Esmailian; Mark D Plunkett; Bernard Kubak
Journal:  Ann Thorac Surg       Date:  2002-11       Impact factor: 4.330

10.  Tricuspid valve regurgitation attributable to endomyocardial biopsies and rejection in heart transplantation.

Authors:  B Hausen; J M Albes; R Rohde; S Demertzis; A Mügge; H J Schäfers
Journal:  Ann Thorac Surg       Date:  1995-05       Impact factor: 4.330

View more
  4 in total

1.  Tricuspid valve regurgitation after heart transplantation.

Authors:  Murray H Kwon; Richard J Shemin
Journal:  Ann Cardiothorac Surg       Date:  2017-05

2.  Tricuspid Valve Regurgitation Immediately After Heart Transplant and Long-Term Outcomes.

Authors:  Muath Bishawi; Giorgio Zanotti; Linda Shaw; Michael MacKenzie; Anthony Castleberry; Karsten Bartels; Jacob Schroder; Eric Velazquez; Madhav Swaminathan; Joseph Rogers; Carmelo Milano
Journal:  Ann Thorac Surg       Date:  2018-12-05       Impact factor: 4.330

3.  Oversized donor heart transplantation-clinical experience with an underestimated problem.

Authors:  Srikanth Kasturi; Thiruthani Kumaran; Varun Shetty; Julius Punnen; Shashiraj Subramanya; Bagirath Raghuraman; Venkat Rao Parachuri; Devi Prasad Shetty
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-05-26

4.  Functional tricuspid valve insufficiency after cardiac transplantation: Which factor is the most important?

Authors:  Vüsal Hajiyev; Michael Dandel; Ruhi Yeter; Felix Schoenrath; Felix Hennig; Volkmar Falk; Christoph Knosalla
Journal:  JTCVS Open       Date:  2020-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.